Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
SentryDx is a cancer diagnostic company. We aim to save lives through diagnosing residual cancer earlier than the current standard of care using a blood draw, called a liquid biopsy. Many different technologies and companies have demonstrated the utility of liquid biopsies. These clinical trials have shown that liquid biopsies can be used to provide better treatment to patients and improve patient disease-free survival. However, lack of regulatory approval has prevented liquid biopsies from becoming the new standard of care. Our goal is to get regulatory approval for our highly accurate method of detecting low-frequency cancer mutations from a blood draw.
Copyright © 2023 SentryDx Cancer Detection - All Rights Reserved.
SentryDx is a NexGen Cancer Detection Company